Active ingredients
Pharmacological Group
Used in the treatment of
- T30 Burn and corrosion, body region unspecified
- N76 Other inflammation of vagina and vulva
- N74.4 Female Chlamydial pelvic inflammatory disease (A56.1+)
- N48.1 Balanoposthitis
- N34 Urethritis and urethral syndrome
- M15-M19 Arthrosis
- M06.9 Rheumatoid arthritis, unspecified
- L30.9 Dermatitis, unspecified
- L20 Atopic dermatitis
- K25 Gastric ulcer
- K26 Duodenal ulcer
- J42 Unspecified chronic bronchitis
- J18 Pneumonia, organism unspecified
- J11 Influenza, virus not identified
- J06 Acute upper respiratory infections of multiple and unspecified sites
- G35 Multiple sclerosis
- G03.9 Meningitis, unspecified
- G03.0 Nonpyogenic meningitis
- D84.9 Immunodeficiency, unspecified
- D48.9 Neoplasm of uncertain or unknown behaviour, unspecified
- B25 Cytomegaloviral disease
- B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- B19 Unspecified viral hepatitis
- B18.2 Chronic viral hepatitis C
- B18.1 Chronic viral hepatitis B without delta-agent
- B17.1 Acute hepatitis C
- B17 Other acute viral hepatitis
- B15 Acute hepatitis A
- B16 Acute hepatitis B
- B00 Herpesviral [Herpes simplex] infections
- A69.9 Spirochaetal infection, unspecified
- A70-A74 Other diseases caused by chlamydia
- A59.0 Urogenital trichomoniasis
- A60 Anogenital herpesviral [herpes simplex] infection
- A56 Other sexually transmitted chlamydial diseases
- Z54.0 Convalescence following surgery
- M32.9 Systemic lupus erythematosus, unspecified
- D84.8 Other specified immunodeficiencies
- B00.1 Herpesviral vesicular dermatitis
- A56.0 Chlamydial infection of lower genitourinary tract
- A08.4 Viral intestinal infection, unspecified